HIV medicine that costs $42000 could be made for just $40 with profits
Lenacapavir drug hailed as 'the closest we have ever been
to an HIV vaccine', is currently sold by US pharma major Gilead at Rs
$42250 for the ... |
Updates & Legacy — Stigmabase is a Canadian Non-Governmental & Nonprofit Initiative. Our mission is to inform about stigma around the world and make the data collected accessible for researchers. Stigmabase is very attentive to misinformation and lists only reliable sources. — The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.